The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)34878-4PMID 7504748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for prostatic carcinoma with prostate specific antigen.

  1992cited by this paper
• Serum prostate specific antigen as pre-screening test for prostate cancer.

  1992cited by this paper
• The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age.

  1992cited by this paper
• The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

  1992cited by this paper
• Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

  1991cited by this paper
• Determination of prostate volume with transrectal US for cancer screening. Part I. Comparison with prostate-specific antigen assays.

  1991cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.

  1990cited by this paper
• Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer.

  1990cited by this paper
• Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens.

  1990cited by this paper
• Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

  1989cited by this paper
• Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.

  1988cited by this paper
• Ultrasound of the prostate

  1988cited by this paper
• Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.

  1988cited by this paper
• Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.

  1987cited by this paper

• Stage A前立腺癌におけるPSA, PSA densityの検討

  2022cites this paper
• Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

  2022cites this paper
• Assessment of Incidence and Prevalence of Prostate Cancer in Middle Aged Male Patients of Western Nepal Using Prostate-specific Antigen and Digital Rectal Examination that Underwent Prostate Biopsy

  2020cites this paper
• A STUDY ON THE F DIFFERENT BIOMARKERS FOR PROSTATE CANCER

  2020cites this paper
• A STUDY ON THE ASSESSMENT OF DIAGNOSTIC ACCURACY OF DIFFERENT BIOMARKERS FOR PROSTATE CANCER

  2019cites this paper
• Comparison of prostate biopsy pathology and radical prostatectomy pathologies

  2019cites this paper
• Contribution of prostate-specific antigen density in the prediction of prostate cancer: does prostate volume matter?

  2018cites this paper
• Title Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen

  2018cites this paper
• PROSTATIC CARCINOMA: CORRELATION OF GLEASON’S SCORE WITH SERUM PSA LEVELS

  2018cites this paper
• Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?

  2016cites this paper
• Is PSA Still the Best Marker in Diagnosis and Monitoring of Prostate Cancer

  2015cites this paper
• Diagnostic Accuracy of BMI and PSA Density in Screening Prostate Cancer Patients in the PSA Diagnostic Gray Zone (4-10 ng/ml)

  2015cites this paper
• The epidemiology and management of prostate cancer in New Zealand

  2015cites this paper
• [Current role of protatic specific antigen (PSA) and its by-products in the diagnosis of prostate cancer].

  2015cites this paper
• PSA Screening: A Discussion Based on the USPSTF Recommendations and the AUA and EAU Guidelines

  2014cites this paper
• Molecular Identification of the Indolent Versus Lethal Tumor

  2013cites this paper
• Analysis of prostate needle biopsy in patients visiting B & B hospital: a three year retrospective study

  2013cites this paper
• Prostate Cancer Tumor Markers

  2012cites this paper
• chapter 98 Prostate Cancer Tumor Markers

  2012cites this paper
• Early Detection, Diagnosis, and Staging of Prostate Cancer

  2012cites this paper
• The Impact of prostate - Specific Antigen Density In Predicting Prostate Cancer

  2011cites this paper
• Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience.

  2011cites this paper
• Safety and Efficacy of Combined Transrectal Ultrasound-Guided Prostate Needle Biopsy and Transurethral Resection of the Prostate

  2010cites this paper
• Utility of Prostate Specific Antigen Density and Free to Total Prostate Specific Antigen Ratio for Detecting Prostate Cancer in Iranian Men: A Prospective Study of 187 Cases

  2010cites this paper
• Prostate kallikrein markers in diagnosis, risk stratification and prognosis

  2009cites this paper
• Patients with Elevated versus Non-Elevated Prostate Specific Antigen Levels before Suprapubic Prostatectomy: Long-Term Postoperative Follow-Up and Risk for Rising Prostate Specific Antigen and Detection of Prostate Cancer

  2009cites this paper
• Die PSA-Density als Parameter zur Verbesserung der Prostatakarzinomdiagnostik

  2008cites this paper
• Prostate-specific antigen density: The role in benign prostate hyperplasia, prostate intraepithelial neoplasm, organ-confined prostate carcinoma and advanced prostate carcinoma

  2007cites this paper
• The value of prostatic specific antigen density in the early diagnosis of prostate cancer

  2006cites this paper
• Age-specific PSA reference ranges in a group of non-urologic patients

  2006cites this paper
• The ratio of prostate‐specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL

  2005cites this paper
• Freies PSA und PSA-Quotient in der Diagnostik des Prostatakarzinoms

  2005cites this paper
• Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients

  2004cites this paper
• Prediction of Free PSA, PSA Density and PSA Density Transition Zone in the Outcome of Sextant Prostate Biopsies in Patients with Total PSA between 3 and 15 ng/ml

  2004cites this paper
• Changing trends of prostate cancer in Asia

  2004cites this paper
• Valor de la densidad del antígeno prostático específico y de la densidad del antígeno prostático específico de la zona transicional en el diagnóstico del cáncer de próstata

  2003cites this paper
• [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].

  2003cites this paper
• REVIEW Clinical usefulness of tumour markers

  2003cites this paper
• Prostate cancer detection by prostate-specific antigen-related parameters.

  2003cites this paper
• Value of prostate specific antigen density and prostate specific antigen density of the transition zone for the diagnosis of prostate cancer

  2003cites this paper
• Prostate-Specific Antigen Levels and Density in the Internal and External Glands of the Prostate in Benign Prostatic Hyperplasia Patients with Normal or Gray-Zone PSA Levels

  2003cites this paper
• The Influence of Prostate Volume on Prostate Cancer Detection

  2002cites this paper
• Clinical Applications of Transrectal Ultrasound in the Prostate and Seminal Tract

  2002cites this paper
• Free and Complexed Prostate-Specific Antigen (PSA) in the Early Detection of Prostate Cancer

  2001cites this paper
• The Role of Prostate Specific Antigen and Its Variants in Prostate Cancer Screening

  2001cites this paper
• Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.

  2001cites this paper
• [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].

  2001cites this paper
• Combined Use of Prostate-Specific Antigen Derivatives Decreases the Number of Unnecessary Biopsies to Detect Prostate Cancer

  2001cites this paper
• Prostate-specific antigen.

  2001cites this paper
• Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.

  2000cites this paper
• Screening for prostate cancer.

  2000cites this paper
• The influence of prostate volume on the prostate‐specific antigen (PSA) level adjusted for the transition zone volume and free‐to‐total PSA ratio: a prospective study

  2000cites this paper
• Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.

  2000cites this paper
• Prostate-specific antigen as a marker of prostate disease

  2000cites this paper
• [Early diagnosis of prostate cancer in patients with prostate symptoms by DRE, PSA, TRU and DPSA].

  1999cites this paper
• Necessity of repeat biopsies in men for suspected prostate cancer

  1999cites this paper
• Prostate‐specific antigen adjusted for the transition zone volume versus free‐to‐total prostate‐specific antigen ratio in predicting prostate cancer

  1999cites this paper
• Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared.

  1999cites this paper
• Prostate‐specific antigen: Current status

  1999cites this paper
• Diagnóstico precoz del cáncer de próstata en pacientes con sintomatología prostática mediante tacto rectal, antígeno específico prostático, ecografía tumorrectal y densidad-psa

  1999cites this paper
• Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.

  1999cites this paper
• Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.

  1999cites this paper
• Population Based Screening for Prostate Cancer: assessment of diagnostic tools and cancers detected

  1998cites this paper
• Prostate cancer detection in candidates for open prostatectomy.

  1998cites this paper
• Impact of Transition Zone Biopsies in Detection and Evaluation of Prostate Cancer

  1998cites this paper
• The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer.

  1998cites this paper
• Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma.

  1998cites this paper
• Improvement of specificity in PSA‐based screening by using PSA‐transition zone density and percent free PSA in addition to total PSA levels

  1998cites this paper
• Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.

  1998cites this paper
• Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination, and transrectal ultrasound and prostate biopsy.

  1998cites this paper
• Relationship among age, prostate‐specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases

  1998cites this paper
• Measurement of complexed PSA improves specificity for early detection of prostate cancer.

  1998cites this paper
• PSA-Screening beim Prostatakarzinom

  1998cites this paper
• Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia.

  1997cites this paper
• [Serum prostate-specific antigen in a urological outpatient clinic. Efficacy of age-specific and prostate volume-specific reference range in detection of prostate cancer].

  1997cites this paper
• Diagnostic value and additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate

  1997cites this paper
• Prostate volume and cancer in screening programs

  1997cites this paper
• Evaluation of Prostate Specific Antigen Density and Transrectal Ultrasonography‐Guided Biopsies in 100 Consecutive Patients with a Negative Digital Rectal Examination and Intermediate Serum Prostate Specific Antigen Levels

  1997cites this paper
• Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.

  1997cites this paper
• Enhancing the specificity of prostate-specific antigen (PSA): an overview of PSA density, velocity and age-specific reference ranges.

  1997cites this paper
• Prostate-specific antigen density.

  1997cites this paper
• Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate.

  1997cites this paper
• Diagnosis, management and screening of early localised prostate cancer.

  1997cites this paper
• The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in japan

  1997cites this paper
• Comparison of three commercial PSA assays: Results of restandardization of the Ciba Corning method

  1997cites this paper
• Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.

  1997cites this paper
• Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

  1997cites this paper
• Prostate-specific antigen as a screening test for prostate cancer. The United States experience.

  1997cites this paper
• The Role of Prostate-Specific Antigen in the Management of Prostate Cancer

  1996cites this paper
• Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy

  1996cites this paper
• [The prostate-specific antigen in the early recognition of prostate carcinoma].

  1996cites this paper
• Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.

  1996cites this paper
• Strip test for the quick detection of increased concentrations of prostate-specific antigen in blood.

  1996cites this paper
• Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy.

  1996cites this paper
• 14 The Role of Prostate-Specific Antigen in the Management of Prostate Cancer

  1996cites this paper
• Age‐specific prostate‐specific antigen: A reassessment

  1996cites this paper
• Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument for.

  1996cites this paper
• The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml.

  1996cites this paper
• Can screening for early-stage prostate cancer be rationalized?

  1996cites this paper
• Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer.

  1996cites this paper